## WTW: Willis Towers Watson Public Lim - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.08 indicates fundamental undervaluation. Quality metrics strong (ROE 28%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($317.42)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Willis Towers Watson subsidiary prices $1 billion in senior notes By Investing.com**
- Source: Investing.com Australia | 20251215T234952 | Bullish | Relevance: 100%
- Willis Towers Watson's (NASDAQ:WTW) indirect wholly-owned subsidiary, Willis North America Inc., has priced a $1 billion offering of senior unsecured notes. The offering, consisting of two tranches due in 2031 and 2036, aims to fund the acquisition of Newfront and refinance existing debt. Several major financial institutions are serving as joint book-running managers for the offering.

**2. NatWest Group (NWG) Share Price This Week: Latest News, Buyback Updates, Analyst Forecasts and the Week Ahead (Updated 14 December 2025)**
- Source: ts2.tech | 20251214T110834 | Neutral | Relevance: 63%
- NatWest Group (NWG) shares ended last week softer, with investors weighing ongoing buybacks against significant UK macro data, including potential Bank of England rate cuts. Key news included the sale of its Cushon stake to WTW, continued share repurchases, positive S&P ratings commentary, and a minority investment in fintech Bourn. The upcoming week's UK labour market data, inflation figures, and the BoE rate decision are expected to be the main drivers for NWG stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $386 | $0 | 0% |
| 2025-12-12 | Wells Fargo | $356 | $362 | -2% |
| 2025-12-12 | Keefe, Bruyette | $375 | $373 | +1% |
| 2025-11-20 | Barclays | $303 | $341 | -11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-12 | Wells Fargo | main | Overweight |
| 2025-12-12 | Keefe, Bruyette | main | Outperform |
| 2025-11-20 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 27 ($0.23M) |
| Sells | 7 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.9%)
- Blackrock Inc.: 9.7% (-4.7%)
- Massachusetts Financ: 6.5% (-0.9%)
- Harris Associates L.: 4.5% (+13.4%)
- State Street Corpora: 4.5% (-0.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Share repurchase program provides demand floor and EPS support.
- Momentum building: MRS_20 improving +6.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Quality metrics strong (ROE 28%, margin 22%). Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.2B |
| Beta | 0.64 |
| 52W Range | $292.97 - $352.79 |
| Short Interest | 3.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | 17.1 |
| Current P/E | 19.4 |
| YoY Growth | 13.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.7% to 3.0% (+6.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.67), confirming momentum. RSI neutral at 60. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.96% (CS: 70) | Neutral |
| RSI_14 | 59.5 | Neutral |
| MACD Histogram | 1.67 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.015x | Above |
| vs SMA200 | 1.027x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $329.76
- **Stop Loss:** $317.42 (3.7% risk)
- **Target:** $354.44 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $31,986.72
- **Portfolio %:** 31.99%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-05 (Est: $7.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.05 | $3.07 | +0.7% |
| 2025Q2 | $2.60 | $2.86 | +10.2% |
| 2025Q1 | $3.19 | $3.13 | -1.8% |
| 2024Q4 | $8.03 | $8.13 | +1.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*